Prostate Cancer and Diseases of the Prostate - Center for Prostate Disease Research

11. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D:
J Urol, 166:1328-31, 2001.

12. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y, Nakamura K, Ko D, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Rhim J:
Oncogene, 20:8036-8041, 2001.

13. Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.
Jani AB, Vaida F, Hanks, G, Asbell S, Sartor O, Moul JW, Raoch M 3rd, Brachman D, Kalokhe U, Muller-Runkel R, Ray P, Ignacio L, Awan A, Weichselbaum RR, and Vijayakumar S:
Int J Cancer, 96:363-371, 2001.

14. Improvements in Pathological Staging for African-American Men Undergoing Radical Retropubic Prostatectomy During the Prostate-Specific Antigen Era – Implications for Screening a High-Risk Group for Prostate Carcinoma.
Paquette EL, Connelly RR, Sesterhenn IA, Zhang W, Sun L, Paquette LR, Greenspan R, Mcleod DG, Moul, JW:
Cancer, 92:2673-2679, 2001.

15. Relationship Between Obesity and Race in Predicting Adverse Pathologic Variables in Patients Undergoing Radical Prostatectomy.
Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, Freidrichs PA, Moul JW:
Urolog, 58:723-728,2001.

16. Managing advanced prostate cancer with Viadur (leuprolide acetate implant).
Moul JW, Civitelli K:
Urol Nurs, 21:385-8, 393-4; quiz 395-6, 2001.

17. Prostate biopsy protocols: 3D visualization-based evaluation and clinical correlation.
Zeng J, Bauer J, Zhang W, Sesterhenn I, Connelly R, Lynch J, Moul J, Mun SK:
Comput Aided Surg, 6:14-21, 2001.

18. The Role of Imaging Studies and Molecular Markers for Selecting Candidates for Radical Prostatectomy.
Moul JW, Kane CJ, and Malkowicz SB:
Urol Clinics of North America, Volume 28, Number 3, August 2001.

19. A Novel Human Cell Culture Model for the Study of Familial Prostate Cancer.
Yasunaga Y, Nakamura K, Ewing CM, Isaacs WB, Hukku B and Rhim JS:
Cancer Research, 61:5969-5973, August 2001.

20. Introduction to department of defense center for prostate disease research (CPDR) multicenter national prostate cancer database with 242,227 records on 11,637 men, and analysis of changes in the PSA-era.
Sun L, Gancarczyk K, McLeod DG, Kane C, Kusuda L, Lance R, Herring J, Foley J, Baldwin D, Bishoff JT, Soderdahl D, Wu H, Xu L, Moul JW.
Urol Oncol 2001.